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Abstract
Background: Infection of glial cells by human neurotropic polyomavirus JC (JCV), the causative agent of the CNS
demyelinating disease progressive multifocal leukoencephalopathy (PML), rapidly inflicts damage to cellular DNA.
This activates DNA damage response (DDR) signaling including induction of expression of DNA repair factor Rad51.
We previously reported that Rad51 co-operates with the transcription factor NF-κB p65 to activate JCV early
transcription. Thus Rad51 induction by JCV infection may provide positive feedback for viral activation early in JCV
infection. DDR is also known to stimulate NF-κB activity, a phenomenon known as nucleus to cytoplasm or “inside-
out” NF-κB signaling, which is initiated by Ataxia telangiectasia mutated (ATM) protein, a serine/threonine kinase
recruited and activated by DNA double-strand breaks. Downstream of ATM, there occurs a series of post-
translational modifications of NF-κB essential modulator (NEMO), the γ regulatory subunit of inhibitor of NF-κB (IκB)
kinase (IKK), resulting in NF-κB activation.
Methods: We analyzed the effects of downstream pathways in the DDR by phosphospecific Western blots and
analysis of the subcellular distribution of NEMO by cell fractionation and immunocytochemistry. The role of DDR in
JCV infection was analyzed using a small molecule inhibitor of ATM (KU-55933). NEMO sumoylation was
investigated by Western and association of ATM and NEMO by immunoprecipitation/Western blots.
Results: We show that JCV infection caused phosphorylation and activation of ATM while KU-55933 inhibited JCV
replication. JCV infection caused a redistribution of NEMO from cytoplasm to nucleus. Co-expression of JCV large T-
antigen and FLAG-tagged NEMO showed the occurrence of sumoylation of NEMO, while co-expression of ATM and
FLAG-NEMO demonstrated physical association between ATM and NEMO.
Conclusions: We propose a model where JCV infection induces both overexpression of Rad51 protein and activation
of the nucleus to cytoplasm NF-κB signaling pathway, which then act together to enhance JCV gene expression.
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Background
The human neurotropic polyomavirus JC (JCV) infects
the oligodendrocytes and astrocytes of the central
nervous system (CNS) causing expanding regions of
demyelination within the white matter that are involved
in the pathogenesis of the fatal demyelinating disease
known as progressive multifocal leukoencephalopathy
(PML) [1]. Primary infection by JCV is very common
and most people are seropositive for JCV beginning at
an early age [2]. In contrast, the occurrence of PML is
rare and is the result of reactivation of persistent virus
usually associated with severe immune dysregulation,
which leads to productive infection of glial cells and
onset of PML [3]. Several types of immune dyfunction
can predispose to the onset of PML and among the most
common are HIV-1/AIDS [4] and treatment with thera-
peutic immunomodulatory drugs used for autoimmune
diseases, e.g., natalizumab in multiple sclerosis patients
[5, 6]. Our understanding of the molecular events of the
JCV life cycle including the reactivation of persistent
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virus and the pathogenesis of PML is continuing to
evolve [2, 3, 7].
JCV is a small DNA tumor virus belonging to the
polyomavirus family that has a ~5.1 Kbp, circular, closed,
supercoiled, double-stranded DNA genome. Both JCV
and Polyomavirus BK (BKV), the causative agent of
BKV-associated nephropathy, were discovered in 1971
and for decades they were the only known human polyo-
maviruses [1, 8]. About 6 years ago, a series of novel
polyomaviruses began to be discovered and this has
brought the number of human polyomaviruses that are
now known to at least ten [9]. The JCV genome is com-
prised of two coding regions, early and late, separated by
a noncoding control region (NCCR), which contains
promoter/enhancer elements and the viral origin of
DNA replication, Ori [10]. The early region encodes
large T-antigen (T-Ag) and small t-antigen and the late
region encodes VP1, VP2, VP3 and agnoprotein. The
coding regions are transcribed in opposite directions
from the NCCR, which is a bidirectional promoter
containing the binding sites for the cellular and viral
transcription factors that regulate JCV gene expres-
sion [11, 12].
Earlier work in our laboratory implicated the NF-κB
signaling pathway and induction of expression of the
Rad51 DNA repair protein as key regulators of the tran-
scriptional status of JCV in the early stages of infection
[13–18]. The JCV NCCR has a unique binding site for
NF-κB and serves as a central nexus for regulation of
JCV transcriptional activity. This site mediates modula-
tion of JCV gene expression in response to a number of
different stimuli including activation of the NF-κB
signaling pathway by cytokines [14], other signal trans-
ducing transcription factors that cooperate or interfere
with NF-κB stimulation such as NFAT4 [15] and C/
EBPβ [13], as well as epigenetic regulatory events involv-
ing protein acetylation [16, 18]. Importantly, Rad51
expression is rapidly induced by JCV infection [19] and co-
operates with NF-κB to stimulate JCV transcription and
providing a positive feedback loop early in infection [17].
Rad51 is a key component of the cellular machinery
for homologous recombination-directed double-strand
break DNA repair that is the eukaryotic homologue of
Escherichia coli RecA and highly conserved over many
species [20, 21]. In an earlier study of JCV infection of
primary human fetal astrocytes [19], we found a substan-
tial induction of DNA damage and genomic instability
reflected in changes in ploidy, increased micronuclei
formation and an induction of the levels of phospho-
histone2AX (γH2AX), a marker for double-strand breaks
that recruits and targets multiple activities involved in
DNA repair [22]. Concomitantly, JCV infection caused
an induction in the expression levels of several enzymes
involved in DNA repair, including a massive elevation in
Rad51 expression [19]. In another other study, we found
that Rad51 binds and activates the p65 subunit of NF-κB
p65 and thus functions as a transcription factor [23, 24].
In the light of this observation, we next investigated a
role for Rad51 on JCV transcription and replication and
found that Rad51 activated transcription of the JCV
early promoter [17]. This activation was co-operative
with NF-κB p65 and could be abrogated either by muta-
tion of the JCV NF-κB binding site or by co-expression
of a dominant negative form of IκBα to sequester NF-κB
indicating that Rad51 induction of JCV transcription
operates through the NF-κB site [17]. Thus Rad51 and
NF-κB are parts of a positive feedback mechanism that
serves to enhance JCV gene expression during the early
stage of viral infection.
In resting cells, NF-κB is sequestered in an inactive
form in the cytoplasm by the inhibitory molecule, IκB,
but can be released upon cellular stimulation allowing
active NF-κB to enter the nucleus and stimulate the
transcription of specific genes [25]. In the case of JCV,
stimulation by extracellular proinflammatory cytokines
such as TNF-α activates NF-κB by this pathway and
strongly stimulates both early and late viral transcrip-
tion, which may have a role in the reactivation of dor-
mant virus [14]. As well as the canonical pathway of NF-
κB activation, the DNA damage response (DDR) is also
known to result in the activation of the NF-κB signaling
pathway, a phenomenon known as nucleus to cytoplasm
or “inside-out” NF-κB signaling [26–28], which is
mediated by NF-κB essential modulator (NEMO), also
known as IKK-γ, a subunit of the IκB kinase complex
that mediates activation of NF-κB. Since JCV infection
results in both the induction of Rad51 expression and
DNA damage, it is possible that DDR-mediated nucleus
to cytoplasm activation of the NF-κB pathway occurs
and that crosstalk between these pathway allows them to
act together to stimulate JCV transcription. In this study,
we examine nucleus to cytoplasm NF-κB signaling in re-
lation to JCV infection of glial cells.
Methods
Cell culture and plasmids
Culture of the human TC620 oligodendroglioma cell line
and SVG-A, a cell line originally derived from human
glial cells transformed by origin-defective SV40 that ex-
presses SV40 T-Ag was as previously described [14, 29].
Expression plasmid pCMV-T-Ag expressing JCV T-
antigen has been previously described [30]. Expression
plasmids for human ATM and FLAG-tagged human
NEMO are from Addgene (Cambridge, MA).
Antibodies
Mouse monoclonal antibody to phospho-ATM (Ser1981,
clone 10H11.E12) and rabbit monoclonal antibodies to
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total ATM (clone D2E2), Chk1 and phospho-Chk1(Ser
317) were from Cell Signaling Technology (Danvers,
MA) and Chk2 and phospho-Chk2(Thr 68) from Santa
Cruz Biotechnology, Inc. (Dallas, TX). Mouse anti-α-
tubulin (clone B512) and anti-FLAG were from Sigma
Aldrich (St. Louis, MO) and mouse anti-lamin A/C
(clone 4C11) was from Cell Signaling Technology.
Mouse monoclonal antibody to T-antigen (Ab-2 PAb416
DP02) was from Calbiochem (La Jolla, CA). Anti-VP1
antibody (AB597) was kindly provided by W. Atwood,
Brown University, Rhode Island). Rabbit polyclonal anti-
JCV agnoprotein antibody was previously described [31].
Reagents
KU-55933(2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-
one), which is an ATP competitive inhibitor of ATM
[32], CP466722 and doxorubicin were purchased from
Sigma Aldrich (St. Louis, MO).
Western blots
Cells were harvested as we have described [13, 33, 34] ex-
cept for experiments to measure sumoylation where
iodoacetemide (10 mM) was added to the lysis and wash
buffers to preserve SUMOylation. Western blots were per-
formed as described [33, 35, 36]. Briefly, 50 μg of protein
was resolved by SDS-PAGE, transferred to nitrocellulose,
and immunoblotted with primary antibody (1/1000 dilu-
tion) and secondary antibody (1/10000 dilution). Bound
antibody was detected with the LI-COR system. Blots
were incubated with IRDye® 680RD Goat Anti-Mouse Li-
COR dyes and visualized with an Odyssey® CLx Imaging
System (LI-COR, Inc., Lincoln, NE) using LI-COR
Odyssey software. Band intensities were quantified using
the Quantity One software (Bio-Rad, Hercules CA) and
intensities normalized to loading control as previously
described [34].
Transient transfection
Transfection of expression plasmids was performed using
Lipofectamine 2000 (Life Technologies Inc., Carlsbad CA)
was performed as we have previously described [33, 34].
The total amount of transfected DNA was normalized
with empty vector DNA.
Immunoprecipitation(IP)/Western blot
TC620 cells were transfected with expression plasmids
for FLAG-NEMO and JCV T-Ag, whole cell extracts
prepared and IP/Western performed as we have de-
scribed [33, 34]. ATM was immunoprecipitated followed
by Western blot for FLAG or vice versa for the recipro-
cal IP/Western.
MTT assay
To assess cell viability after treatment, the MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)
assay was performed with 5 mg/ml MTT (Amresco,
Solon, OH) using an absorbance reader to determine
optical density at a wavelength of 570 nm.
JCV Infection
Infection experiments were performed with SVG-A cells.
Cells were transfected with expression plasmids or
treated with KU-55933 as specified in the respective
Figure Legends and infected with Mad-1 JCV at an MOI
of 1 as we have previously described [37, 38], harvested
and analyzed after 7 days together with uninfected control
cultures. Expression of the viral proteins VP1 and agno-
protein was measured in whole cell protein extracts by
Western blot. In parallel, the growth medium of the cells
was also collected to measure viral load by Q-PCR [38].
Cell fractionation
SVGA cells were infected with Mad-1 JCV at an MOI of
1 and harvested at various time points after infection to
isolate nuclear and cytoplasmic fractions using the NE-
PER nuclear and cytoplasmic extraction kit according to
the manufacturer’s instructions (Thermo Scientific
Pierce, Rockford IL; Cat. #PI-78835) as we have previ-
ously described [17, 33, 35].
Immunocytochemistry (ICC)
ICC was performed as we have recently described [17].
SVGA cells were infected with wild-type Mad-1 JCV and
transfected twice with expression plasmid for FLAG-
NEMO on days 2 and 5 postinfection. Cells were fixed
in 4% paraformaldehyde, in PBS for 10 min, washed,
permeabilized for 5 min with 0.1% Triton X-100,
blocked with 5% normal goat serum for 30 min and in-
cubated for 3 h at 37°C with mouse anti-FLAG or mouse
anti-VP1 antibody at a 1:100 dilution in PBS. Cells were
then washed, incubated for 2 h with secondary FITC-
conjugated goat anti-mouse secondary antibody at a
1:200 dilution, washed, mounted with 4',6-diamidino-2-
phenylindole (DAPI)-containing mounting medium
(VECTASHIELD, Vector Laboratories Inc. Burlingame,
CA), and viewed by fluorescence microscopy.
Results
JCV infection of glial cells results in phosphorylation of
ATM
The first step in nucleus to cytoplasm NF-κB signaling is
the activation and autophosphorylation of ATM, a
serine/threonine-specific protein kinase that is recruited
and activated by double-strand DNA breaks. It
phosphorylates several key signaling proteins that initiate
cellular responses to DNA damage including p53,
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CHK2, BRCA1, NBS1, H2AX and NEMO [39]. First, we
examined the phosphorylation of ATM Ser1981, the
serine residue upon which ATM is autophosphorylated
in response to DNA damage [40]. As shown in Fig. 1a,
Western blot with a phosphospecific antibody to ATM
showed that phospho-ATM is increased 5 days after JCV
infection of SVGA cells. Total ATM and the loading
control α-tubulin were unchanged.
ATM inhibition restrains JCV infection of glial cells
To further investigate the role of ATM in JCV infection,
SVGA were infected with JCV and treated with or
Fig. 1 Role of ATM phosphorylation in JCV infection. a Effect of JCV infection on ATM phosphorylation. SVGA cells were uninfected or infected, as indicated,
with the Mad-1 strain of JCV at moi = 1 for 5 days and harvested. Fifty micrograms of total cell extract were loaded onto a 6% polyacrylamide SDS gel,
electrophoresed and analyzed by Western blot for phospho-ATM and total ATM. Alpha-tubulin (α-Tub) was the loading control. The intensity of the p-ATM
band in each lane was quantified using the ImageQuant software (Molecular Dynamics, GE Healthcare Bio-Sciences, Pittsburgh PA) and these are shown in
the lower part of the panel. b Effect of ATM inhibition on JCV infection. SVGA were infected with the Mad-1 of JCV and treated with or without KU-55933(2-
morpholin-4-yl-6-thianthren-1-yl-pyran-4-one; 5 μM or 10 μM), which is ATP competitive inhibitor of ATM, as indicated. Cells were harvested and expression of
VP1 and agnoprotein measured by Western blot. The loading control was α-Tubulin. The intensity of the VP1 and Agno bands in each lane was quantified
using the ImageQuant software and these are shown in the lower part of the panel. c Culture supernatants from the cells in Panel b were assayed for virus
using qPCR. Each viral load was measured in triplicate and presented as a histogram with the standard deviation shown as an error bar. d The viability of
SVGA cells was assayed at different concentrations of KU-55933 by MTT assay as described in the Methods section. Each viability was measured in triplicate
and presented as a histogram with the standard deviation shown as an error bar. e Effect of different ATM inhibitors on JCV infection. SVGA were infected with
the Mad-1 of JCV and treated with or without KU-55933 or CP466722 as indicated. Cells and supernatants were harvested and viral copy number in the
culture medium assayed by QPCR. Expression of VP1 was measured by Western blot with α-Tubulin as the loading control (shown inset). f Effect of JCV
infection or doxorubicin treatment on ATM phosphorylation. SVGA cells were uninfected or infected, as indicated, with the Mad-1 strain of JCV at moi = 1 or
treated with 2.5 μM doxorubicin for the times indicated and harvested. Western blots were performed for phospho-ATM and total ATM. Alpha-tubulin was
the loading control. The intensity of the p-ATM band in each lane was quantified using the ImageQuant software and these are shown in the lower part of
the panel.
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without KU-55933, which is an ATP competitive inhibi-
tor of ATM. Culture supernatants were assayed for virus
by qPCR and cells were harvested at different time
points and samples were used for Western blots for viral
proteins. KU-55933 caused a reduction in viral protein
expression compared to control (Fig. 1b) and likewise a
reduction in the virus load in the culture supernatants of
infected cells (Fig. 1c). At the concentrations used, KU-
55933 had no toxic effects on cells as measured by MTT
assay (Fig. 1d). To verify the effect of ATM inhibition,
we also employed CP466722, a second inhibitor of ATM
structurally unrelated to KU-55933. CP466722
suppressed viral copy number down from 1.5 × 105 to
1.9 × 104 compared to 0.8 × 104 for KU-55933 (Fig. 1e).
Comparison of JCV infection of glial cells to treatment
with a chemical activator of the DDR on the
phosphorylation of ATM
To compare to the induction phospho-ATM in response to
JCV infection to treatment with doxorubicin, a known
chemical activator of the DDR, SVGA were infected with
JCV for 3d and 7d or treated with doxorubicin for 3d and
5d (7d treatment was toxic to the cells). Both JCV infection
and treatment with doxorubicin caused induction phospho-
ATM of a comparable order of magnitude (Fig. 1f).
JCV infection causes the phosphorylation of proteins in
the ATM kinase signal transduction pathway
The activation of the serine/threonine-specific protein
kinase, ATM, is the upstream event in a signal transduc-
tion pathway, which is initiated in response to DNA
damage. In order to further explore the activation of the
DNA damage response, we investigated the phosphoryl-
ation/activation status of the intermediate protein
kinases Chk1 (Fig. 2a) and Chk2 (Fig. 2b) in this path-
way using phospho-specific antibodies. For each, the
amount of total Chk1 and Chk2 protein was also mea-
sured and phosphorylation was normalized to this
(Fig. 2c & d). Additionally, the levels of loading controls
were measured for each Western by quantifying expression
of glyceraldehede-3-phosphate dehydrogenase (Fig. 2e) or α-
tubulin (Fig. 2f). The levels of Chk1 and Chk2 phosphoryl-
ation were increased by 2.9-fold and 3-fold respectively
when cells were infected by JCV. Thus both Chk1 and Chk2
are activated by JCV infection.
JCV infection causes the subcellular redistribution of
NEMO to the nucleus as determined by subcellular
fractionation
Downstream of ATM, there are a series of post-translational
modifications of the NF-κB essential modulator (NEMO),
Fig. 2 Phosphorylation of CHK1 and CHK2 in JCV infection. SVGA cells were infected with Mad-1 JCV at an moi of 1 and cultured for 5 days. Total cell lysates
were harvested and analyzed by Western blots for phospho-Chk1(Ser 317), Panel a and phospho-Chk2(Thr 68), Panel b. The Western membranes were
reprobed for total Chk1 (a) and Chk2 (b) and then for a loading control, which was either glyceraldehyde-3-phosphate dehydrogenase (GAPDH, a) or
α-tubulin (α-TUB, b). The intensity of each band was quantified using the IMAGEQUANT software (Molecular Dynamics, GE Healthcare Bio-Sciences, Pittsburgh
PA) and the ratio of phospho-Chk1 to Chk1 (c) and phospho-Chk2 to Chk2 (d) calculated and shown as histograms expressed as a percentage of the signal
in uninfected cells. Similarly, the loading controls were quantified (e and f)
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which occur after NEMO is translocated to the nucleus
[41]. To investigate NEMO translocation, SVGA cells were
transfected with expression plasmid for FLAG-NEMO, in-
fected with JCV and harvested at various time points after
infection to isolate nuclear and cytoplasmic fractions.
Western blot for α-FLAG showed that NEMO underwent
translocation from the cytoplasm to the nucleus, which was
maximal at 3 days following infection (Fig. 3). The integrity
of the cytoplasmic and nuclear fractions was verified by
Western blot for α-tubulin and lamin A/C respectively.
Infection was monitored by Western blot for VP1.
JCV infection causes the subcellular redistribution of
NEMO to the nucleus as determined by
immunocytochemistry
In another experiment, NEMO translocation was inves-
tigated by immunocytochemistry. SVGA cells were
infected with Mad-1 JCV and transfected twice with
FLAG-NEMO (days 2 and 5) and analyzed by immuno-
cytochemistry for FLAG and VP1 on day 7. As shown in
Fig. 4, the distribution of NEMO was revealed by an α-
FLAG antibody (FITC, green) and nuclei by DAPI
(blue). It was again found that NEMO translocates from
the cytoplasm to the nucleus upon JCV infection (com-
pare Fig. 4b and c).
JCV large T-Ag causes the sumoylation of NEMO
After translocation to the nucleus, NEMO undergoes
post-translational modification by the covalent attach-
ment of SUMO and ubiquitin [41]. In the next experi-
ment, we transfected cells with expression plasmids for
FLAG-tagged NEMO with or without co-transfection of
an expression plasmid for JCV T-Ag. Western blots were
performed with antibody to the FLAG epitope to detect
unmodified NEMO and NEMO, which is sumolyated
and/or ubiquitinated and thus migrates at a higher
molecular weight (Fig. 5a). Both unmodified and modified
forms of NEMO were detected in cells transfected with
FLAG-NEMO and modified NEMO was increased about
5.5-fold in the presence of JCV T-Ag indicating that T-Ag
is involved in NEMO sumoylation/ubiquitination.
ATM and NEMO physical associate with each other
In the next step of nucleus to cytoplasm NF-κB activa-
tion, NEMO associates with activated ATM and ATM
phosphorylates NEMO to promote its ubiquitin-
dependent nuclear export [42]. To investigate physical
association between ATM and NEMO, we transfected
cells with expression plasmids for ATM and FLAG-
NEMO and used whole cell extract for immunoprecipi-
tation with an antibody to ATM. Western blot with α-
FLAG antibody to detect NEMO, showed that NEMO
had co-immunoprecipitated with ATM but not in the
nonimmune rabbit serum (NRS) negative control
(Fig. 5b). Reciprocally when whole cell extract was
immunoprecipitated with mouse anti-FLAG to immuno-
precipitate NEMO, ATM was co-immunoprecipitated
but in the nonimmune mouse serum (NMS) negative
control (Fig. 5c). We conclude that ATM and NEMO
physically associate with each other.
Discussion
Here we report that infection of glial cells by JCV acti-
vates the nucleus to cytoplasm or “inside out” pathway
of NF-κB signaling. The first step in this pathway is acti-
vation of the ATM by DNA damage serine/threonine-
specific protein kinase, which can be measured by phos-
phospecific Western blot for the autophosphorylated
form of the protein (Ser1981) that is the activated form
[39]. This finding was not surprising since we have
already reported that phosphorylation of H2AX, a down-
stream target of ATM in the DDR, occurs after JCV
Fig. 3 Role of NEMO cytoplasm to nucleus translocation in JCV infection: Analysis of the effect of JCV infection on the subcellular distribution of
NEMO by cell fractionation. SVGA cells were transfected with expression plasmid for FLAG-NEMO and infected with wild-type Mad-1 JCV 24 h
later. Cells were harvested at 1, 3, 4 and 5 d after infection and fractionated into cytoplasmic and nuclear fractions. Western blot for α-FLAG was
used to monitor the subcellular distribution of NEMO. Western blots for α-tubulin and lamin A/C were used to monitor cell fraction purity and for
VP1 to monitor infection
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infection [19]. We also investigated the phosphorylation
of two other signaling intermediates downstream of
ATM, the checkpoint kinases Chk1 and Chk2 and found
that they are both activated by phosphorylation on
serine 317 (Chk1) and threonine 68 (Chk2).
A key step downstream of ATM in nucleus to cyto-
plasm NF-κB activation is the translocation of NEMO to
the nucleus and its sumoylation. We now report that
both of these events occur after JCV infection. Interest-
ingly, it is known that NEMO translocation and sumoy-
lation is independent of ATM activation [41]. Indeed,
other stress conditions, including oxidative stress, etha-
nol exposure, heat shock and electric shock, also induce
NEMO SUMOylation [43]. Thus DNA damage per se is
not necessary for sumoylation of NEMO to occur. The
nature of the stress incurred by JCV infection that
induces NEMO sumoylation is not known but it is
possible that the oncogenic stress arising from the dis-
ruption of multiple cellular signaling pathways by T-Ag
expression may be involved [44] in addition to the effect
of DNA damage.
While the NEMO sumoylation step is ATM-
independent, it causes NEMO to be retained in the
nucleus and allows subsequent ATM-dependent phos-
phorylation and ubiquitylation of NEMO to ultimately
activate cytoplasmic IKK [41]. A schematic model of the
DDR and NF-κB pathways and their cross-interaction in
regulating JCV is shown in Fig. 6.
From earlier studies, it is known that active NF-κB
translocation to the nucleus [45, 46] stimulates tran-
scription of NF-κB-dependent genes including both the
early and late genes of JCV as described in our earlier
studies [13–18, 35, 36]. JCV infection-induced DDR sig-
naling is associated with a large elevation in the expres-
sion level of Rad51 protein [19], which then physically
associates with NF-κB and augment its function [23]
and stimulate transcription of JCV early gene expression
Fig. 4 Role of NEMO cytoplasm to nucleus translocation in JCV
infection: Analysis of the effect of JCV infection on the subcellular
distribution of NEMO by immunocytochemistry. SVGA cells were
uninfected and untransfected (a) or uninfected and transfected with
expression plasmid for FLAG-tagged NEMO (b). SVGA cells were also
infected with wild-type Mad-1 JCV and transfected twice with expression
plasmid for FLAG-NEMO on days 2 and 5 postinfection (c). Control cells
were infected with JCV but not transfected (d). Immunocytochemistry for
FLAG and VP1 was performed on day 7 postinfection as described in the
Methods section
Fig. 5 Role of NEMO sumoylation in JCV infection and NEMO
association with ATM. a Effect of JCV T-antigen on Sumoylation
of NEMO. TC620 cells were transfected with expression plasmids for FLAG-
tagged NEMO and/or T-Ag. Western blots were performed with antibody
to T-Ag and anti-FLAG antibody to detect NEMO and sumoylated NEMO
(arrowhead) as indicated. The quantified intensity of the sumoylated
NEMO band is indicated in the histogram directly below the Western. The
intensity of the sumoylated band as a percentage of total NEMO with and
without T-Ag is presented in the lower right-hand part of the panel. b
Physical association between ATM and NEMO. TC620 cells were transfected
with expression plasmids for ATM and FLAG-NEMO. Whole cell extract
(Input, lane 1) was immunoprecipitated with rabbit anti-ATM (lane 3). Non-
immune rabbit serum (NRS) was the negative control (lane 2). Western
blot was with α-FLAG antibody. c In a reciprocal immunoprecipitation,
whole cell extract from Panel b (Input, lane 1) was immunoprecipitated
with mouse anti-FLAG (lane 3). Nonimmune mouse serum (NMS) was the
negative control (lane 2). Western blot was with α-ATM antibody
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[17]. Activation of JCV transcription by Rad51 is abro-
gated by mutation of the NF-κB binding site or addition
of siRNA to NF-κB p65 [17]. This indicates that Rad51
induction resulting from JCV infection with JCV acts
through NF-κB to stimulate JCV early transcription.
Since we now show NF-κB activation is itself induced by
JCV infection, this suggests the operation of a novel
two-part positive feedback mechanism that enhances
viral gene expression early in infection.
The induction of the DDR by infection may be a gen-
eral feature of polyomaviruses [47] as indeed is also the
case for many other types of both DNA and RNA
viruses [48–51]. The closely related BKV has also been
reported to induce the DDR: infection of the natural
host cells of the virus, renal proximal tubule epithelial
(RPTE) cells, activated both the ATM and the ATR
(ATM and Rad3-related) DDR [52]. Knockdown of ATM
or ATR by RNA interference reduced BKV replication
and virion production while double knockdown had an
additive effect indicating that DDR induction is critical
for productive BKV infection [52]. Further analysis re-
vealed that neither input virus nor expression alone was
sufficient to trigger ATM or ATR activation but rather
ATM- and ATR-mediated DDR is associated with viral
DNA replication [53]. For the rhesus macaque monkey
polyomavirus SV40, infection of permissive CV1 or
BSC40 monkey cells causes activation of ATM signaling
[54, 55], H2AX phosphorylation and Mre11-Rad50-Nbs1
assembly with T-antigen together with other DDR-
signaling proteins in viral replication foci. Inhibition of
ATM kinase showed that this is a prerequisite for opti-
mal viral replication [55]. Hein et al. [56] found that
expression of SV40 large T-antigen alone, without a viral
replication origin, induced DDR markers including γ-
H2AX, p53 nuclear foci and other signaling components
downstream of ATM and ATR kinases such as CHK1
and CHK2. Large T-antigen also induced apparent DNA
damage as measured by COMET assay, the Fanconi
anemia pathway and Rad51 foci [57]. It was further
demonstrated using Rad51 siRNA that Rad51 is required
for efficient viral replication [57] similar to the role of
Rad51 that we have reported in JCV replication [17]. Activa-
tion of the ATM pathway has also been reported for mouse
polyomavirus [58] and human Merkel cell carcinoma virus
[59]. In addition to polyomaviruses, DDR activation as a
general feature of other viruses including herpesviruses [60]
and papillomaviruses [61]. For example, Kaposi sarcoma-
associated herpes virus (KSHV) expresses genes which se-
lectively modulate the DDR through the activation of the
ATM pathway [60] and human papillomavirus (HPV) acti-
vates both the ATM and ATR DDR pathways [61].
In the case of JCV, besides our study described here,
there is one other report of the activation of ATM by
viral infection [62]. In this report, infection by JCV or
transient transfection with a T-Ag expression plasmid
resulted in activation of ATM and ATR causing cells to
accumulate in the G2 phase of the cell cycle. Inhibition
of ATM and ATR by caffeine suppressed JCV replication
and virus production [62]. These studies showed the role
of ATM and ATR signaling in the JCV life cycle. How-
ever, our study described here is the first to report the
involvement of the nucleus to cytoplasm pathway of NF-
κB activation downstream of ATM by JCV or by any
other polyomavirus.
Fig. 6 Schematic representation of the nucleus to cytoplasm NF-κB activation pathway in JCV infection. Infection of glial cells by JCV results in
stress leading to NEMO sumoylation in the nucleus ① and activation of the DDR ②, which phosphorylates and activates ATM ③. Activated ATM
binds NEMO and leads to phosphorylation of NEMO on Ser85 ④, which is involved in NEMO ubiquitination and export from the nucleus ⑤ to
the cytoplasm. ATM and NEMO activate IKK ⑥, which phosphorylates IκB leading to IκB degradation ⑦ and release of NF-κB ⑧ to migrate to the
nucleus ⑨. Meanwhile, Rad51 is induced by the DDR ⑩ and associates with nuclear NF-κB ⑪ to activate JCV transcription⑫
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Conclusions
In summary, our results reported here describe the novel
finding that DNA damage following JCV infection by
JCV activates ATM and initiates nucleus to cytoplasm
NF-κB signaling. In this way, JCV is able to enhance ex-
pression of its own genes and promote the viral life
cycle, which may be important in the pathogenesis of
PML since it provides potential positive feedback during
viral reactivation.
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